Increscent® is MPEG LA’s innovative biotechnology platform for the design and development of cell-targeting multimeric oligonucleotides for enhanced therapeutic potency and precision. MPEG LA is currently working in collaboration with drug developers to address new therapeutic targets and improve existing ones. Customizable licenses and collaboration agreements are available, including exclusive licenses for discrete fields of use. For further information on the technology and partnering/licensing opportunities, please contact our Biotech Group.
Increscent® Advantage
Increscent® Overview
Increscent® Data Package
OTS Poster 2021: CpG-miRNA multimeric conjugates
OTS Poster 2019: GalNAc-siRNA multimeric conjugates
Increscent® Paper
Increscent® News
Upcoming Events
- AUTM Annual Meeting (March 15-18, 2021)
- Nucleic Acid Therapies, Cold Spring Harbor Laboratories (March 24-26, 2021)
- HMS Initiative for RNA Medicine, 6th Annual Symposium (April 29, 2021)
- BIO International (June 14-17, 2021)
- RNA Therapeutics Symposium: From Concept to Clinic (June 23-25, 2021)
- TIDES USA (September 13-16, 2021)
- OTS Annual Meeting (September 26-29, 2021)